Management of a Patient With Myocardial Infarction With Non-obstructive Coronary Arteries (MINOCA) Secondary to

Namratha Edpuganti1, Basil N Nduma2, Chukwuyem Ekhator3

  • 1Internal Medicine, Mamata Medical College, Khammam, IND.

Cureus
|February 3, 2025
PubMed

Insights

Myocardial infarction with non-obstructive coronary arteries (MINOCA) diagnosis is challenging due to varied causes. Advanced imaging like cardiac MRI is crucial for identifying the specific MINOCA etiology, such as myopericarditis, enabling tailored treatment.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Myocardial infarction with non-obstructive coronary arteries (MINOCA) poses diagnostic and management challenges.
  • Etiologies are diverse, including myopericarditis, coronary vasospasm, microvascular dysfunction, embolism, and takotsubo syndrome.
  • Lack of consensus guidelines complicates the optimal approach to MINOCA.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
446
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
129